SiliconInvestor
     Advanced Search   [ sign in ]

register
Sponsor		  register
Register

 Biotech / Medical : Biotech Valuation

 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  
To: Clarksterh who wrote (30069)2/3/2009 12:14:44 AM
From: DewDiligence_on_SI1 Recommendation  Read Replies (2) of 40233
 
? Obviously there are companies that do not value innovation - because the flip side of innovation is risk.

Companies such as PFE that spend tens of billions per year on R&D are, tautologically, willing to assume large amounts of risk. The problem is that not all scientists are created equal. DNA has been hiring the cream of the crop and leaving the dregs (relatively speaking) for the Pfizers, Glaxos and Sanofis.
Report TOU ViolationShare This Post
 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQ
Copyright © 1995-2013 Knight Sac Media. All rights reserved.